CJC-1295 (No DAC), Ipamorelin
Also known as No DAC, CJC-1295 (No DAC), CJC-1295 without DAC, CJC-1295 (pulsatile)
CJC-1295 (No DAC) and Ipamorelin form a clean, beginner-friendly GH duo that gently amplifies your natural growth hormone pulses for muscle growth, fat loss, and recovery without the hunger or side effects of stronger secretagogues. CJC-1295 mimics the brain’s GH-releasing hormone for short, physiologic bursts, while Ipamorelin selectively activates GH pathways without raising cortisol, prolactin, or appetite—making it one of the safest options.
Route
Subcutaneous injection
Dose range
333 mcg – 2 mg
Frequency
Ipamorelin daily; CJC-1295 DAC once per week
Cycle length
12–16 weeks

CJC/IPA 10MG
Third-party tested, lot traceable, ships in 3–5 business days.
Overview
CJC-1295 (No DAC) and Ipamorelin form a clean, beginner-friendly GH duo that gently amplifies your natural growth hormone pulses for muscle growth, fat loss, and recovery without the hunger or side effects of stronger secretagogues. CJC-1295 mimics the brain’s GH-releasing hormone for short, physiologic bursts, while Ipamorelin selectively activates GH pathways without raising cortisol, prolactin, or appetite—making it one of the safest options. This synergy can double or triple GH secretion compared to either alone, promoting lean tissue gains and efficient fat burning, especially during sleep when GH naturally peaks.
Common benefits spotlight improved body composition, deeper restorative sleep, faster workout recovery, and subtle anti-aging effects like better skin elasticity and joint comfort. Users appreciate the lack of bloating or lethargy, with visible abs definition and strength plateaus breaking after consistent use. It’s perfect for women, older adults, or anyone new to peptides seeking natural hormone enhancement without extremes. Typically injected before bed, it aligns with your body’s rhythm for sustained IGF-1 elevation and metabolic health. For long-term wellness, this stack supports immune function, bone density, and cognitive clarity, offering research-supported GH optimization that’s gentle yet effective for everyday vitality.
Studied benefits
- One of the most popular and versatile stacks
- It promotes lean muscle mass and fat oxidation by mimicking natural GH pulses
- It is highly selective, meaning it does not stimulate hunger or affect cortisol/prolactin levels
Reported side effects
- Very low side-effect profile
- most common are mild injection-site reactions, transient flushing, or a slight headache
Protocol
Dosing Schedule (Subcutaneous)
Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.
CJC-1295 No DAC + Ipamorelin (10mg Blend)
Reconstitute with 2.0 mL bacteriostatic water (Final concentration: 5 mg/mL total; 2.5 mg/mL each).
Maximize natural Growth Hormone (GH) pulses through GHRH/GHRP synergy with minimal side effects.
CJC-1295 No DAC + Ipamorelin (20mg Blend)
Reconstitute with 3.0 mL bacteriostatic water (Final concentration: ~6.67 mg/mL total; ~3.33 mg/mL each).
Sustained GH elevation and body composition support using a high-concentration blend.
CJC-1295 DAC + Ipamorelin (10mg Blend)
Reconstitute with 2.0 mL bacteriostatic water (Final concentration: 5 mg/mL total).
Provide baseline GH elevation (DAC) with acute pulse stimulation (Ipamorelin).
CJC-1295 DAC + Ipamorelin (20mg Blend Vial)
Reconstitute with 3.0 mL bacteriostatic water (Final concentration: ~6.67 mg/mL total).
Enhanced long-term GH support combined with acute pulse stimulation for muscle recovery and fat loss.
| Phase | Dose Type | Draw at 5 mg/mL | Log |
|---|---|---|---|
| Daily | 333 mcg Ipamorelin | 6.7 units (0.067 mL) | + Log |
| Weekly | 2,000 mcg CJC-1295 DAC | 40 units (0.4 mL) | + Log |
Frequency
Ipamorelin daily; CJC-1295 DAC once per week.
Timing
Ipamorelin at bedtime on an empty stomach.
Cycle length
12–16 weeks.
Unit calculator
Set your vial and water; the table above updates.
5 mg/mL
30 doses of 333 mcg per vial
At the starting dose (333 mcg × 1/week for a 12-week cycle) you would use about 4 mg, i.e. 1 × 10 mg vial. Higher phases use proportionally more.
Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.
Context
Lifestyle considerations
Maintain a high-protein, balanced diet to support the steady, more "natural" growth hormone pulses generated by this popular and side-effect-friendly combination. Incorporate regular physical activity to stimulate blood flow and growth factor release, which works in tandem with the blend's regenerative profile. Ensure 7–9 hours of quality sleep to facilitate the deep-sleep GH peaks that these peptides are designed to enhance. This blend is often favored for its lack of appetite stimulation, making it ideal for those maintaining a lean physique while focusing on long-term recovery and anti-aging research.
Evidence
Research summaries
Ipamorelin: A Selective Growth Hormone Secretagogue Without Side Effects
Findings: Increases growth hormone without triggering stress hormones (cortisol) or hunger, making it the "cleanest" option.
This pair is often called the "Gold Standard" or "No-Bloat" stack because it is so precise. In a landmark study, scientists compared Ipamorelin to other peptides and found something unique: it released growth hormone but did not release ACTH (which causes stress) or prolactin (which causes side effects like water retention). When you mix this "sniper-like" peptide with CJC-1295 (no DAC), which amplifies the signal, you get a pure pulse of growth hormone that mimics the body’s natural youth rhythm. This makes it ideal for anti-aging or fat loss where you don't want the side effects of feeling jittery, hungry, or holding water weight.
Read the study ↗Complementary Action of GHRH and Ghrelin Mimetics
Findings: Uses two different "keys" to unlock the pituitary gland, doubling the effectiveness without doubling the dose.
Imagine trying to launch a rocket. CJC-1295 is the launch pad, and Ipamorelin is the fuel. Research shows that CJC-1295 works on the "GHRH receptor," while Ipamorelin works on the "Ghrelin receptor." Because they don't fight for the same parking spot, they work perfectly together. The CJC-1295 wakes up the gland, making it sensitive, and then Ipamorelin triggers the release. This combination provides a consistent, reliable rise in IGF-1 (Insulin-like Growth Factor 1), which burns fat and tightens skin, without the "rollercoaster" ups and downs of stronger blends. It is considered the safest research protocol for long-term use.
Read the study ↗More references (6)
- Guidelines for using CJC-1295 with Ipamorelin, 2025
- Mechanisms of Ipamorelin and CJC-1295 synergy, 2023
- Compounded Ipamorelin and CJC-1295 Safety Risks (FDA), 2022
- Ipamorelin as a therapeutic for gastric motility disorders, 2014
- Effect of CJC-1295 on GH and IGF-1 levels in healthy adults, 2006
- Ipamorelin: First selective GH secretagogue with high potency, 1998
Identification
Chemistry
- common names
- CJC-1295 (No DAC), CJC-1295 without DAC, CJC-1295 (pulsatile), Mod GRF (1-29), Modified GHRH (1-29), GRF (1-29) analog, MOD-GRF, Modified Growth Hormone-Releasing Factor (1-29), CJC-1295 free form; Ipamorelin, NNC-26-0161, GHS-R1a selective agonist, selective growth hormone secretagogue, ghrelin mimetic pentapeptide, ipamorelin acetate (salt form); Blend Designation: CJC-1295 (No DAC)/Ipamorelin blend, Mod GRF/Ipamorelin combination, CJC-1295/Ipamorelin peptide blend, two-component growth hormone secretagogue blend
- cas
- 446036-97-1
- formula
- C₁₅₂H₂₅₂N₄₄O₄₂
- molecular weight
- 3,367.79–3,369.1 Da (g/mol)
- sequence
- Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂
- source
- Synthetic (laboratory-manufactured)
- biosynthesis
- Non-ribosomal synthesis via chemical peptide synthesis
- type
- Linear pentapeptide with two D-amino acids, alpha-methylated N-terminus, and specialized 2-naphthylalanine residue
Keep exploring
Related peptides
5-Amino-1MQ
5-amino-1-methylquinolinium · NNMTi
- Route
- Subcutaneous
- Dose
- 2.5 mg – 5 mg
- Cycle
- 10–20 days (based on a single 50 mg vial)
AICAR
Acadesine · AICA-Riboside
- Route
- Subcutaneous
- Dose
- 1 mg – 3 mg
- Cycle
- 8–12 weeks
BPC-157, TB-500
- Route
- Subcutaneous
- Dose
- 333 mcg – 667 mcg
- Cycle
- 8–12 weeks
CJC-1295 (No DAC)
No DAC
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 8–12 weeks